Investigate the benefit in modifying the treatment plan during a course of proton therapy in pancreatic and liver cancer.
Not Applicable
- Conditions
- Pnacreatic cancerLiver cancerpancreatic cancer, liver cancerMeSH C04.557.470.200.025.232.750, MeSH C04.588.274.623
- Registration Number
- JPRN-jRCT1012230030
- Lead Sponsor
- chinami Yusuke
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Patients who are 20 years of age or older at the time of obtaining consent
ECOG performance status is 0
Patients with pathologically confirmed malignancy or clinically diagnosed malignancy
No evidence of distant metastasis
Judged to be appropriate for proton therapy by multidisciplinary tumor board
Exclusion Criteria
In patients with pacreatic cancer, previous treatment of radiotherapy or surgery
Pregnant women or those who are breastfeeding
Judged by the principal investigator to be inappropriate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method